Terms: = Uterine cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1
10 results:
1. cyp2d6 and CYP2E1 Gene Polymorphisms and their Association with Cervical cancer Susceptibility: A Hospital Based Case-Control Study from South-Western Maharashtra.
Datkhile KD; Durgawale PP; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2591-2597. PubMed ID: 36037111
[TBL] [Abstract] [Full Text] [Related]
2. Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs.
Elnakib HE; Ramsis MM; Albably NO; Vector MA; Weigand JJ; Schwedtmann K; Wober J; Zierau O; Vollmer G; Abadi AH; Ahmed NS
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830456
[TBL] [Abstract] [Full Text] [Related]
3. CYP1A1 and cyp2d6 gene polymorphisms in Israeli Jewish women with cervical cancer.
Gutman G; Morad T; Peleg B; Peretz C; Bar-Am A; Safra T; Grisaru D
Int J Gynecol Cancer; 2009 Nov; 19(8):1300-2. PubMed ID: 20009880
[TBL] [Abstract] [Full Text] [Related]
4. Allelic variations in cyp2d6 gene and susceptibility to cervical cancer.
Wajid S; Naqvi SH; Juneja A; Bharadwaj M; Mitra AB
Drug Metab Lett; 2007 Dec; 1(4):276-80. PubMed ID: 19356055
[TBL] [Abstract] [Full Text] [Related]
5. HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease.
Zoodsma M; Nolte IM; Te Meerman GJ; De Vries EG; Van der Zee AG
Int J Oncol; 2005 Mar; 26(3):769-84. PubMed ID: 15703836
[TBL] [Abstract] [Full Text] [Related]
6. Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans.
White IN
Curr Drug Metab; 2003 Jun; 4(3):223-39. PubMed ID: 12769667
[TBL] [Abstract] [Full Text] [Related]
7. Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium.
Hukkanen J; Mäntylä M; Kangas L; Wirta P; Hakkola J; Paakki P; Evisalmi S; Pelkonen O; Raunio H
Pharmacol Toxicol; 1998 Feb; 82(2):93-7. PubMed ID: 9498238
[TBL] [Abstract] [Full Text] [Related]
8. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and cyp2d, on chromosome 22q.
Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
[TBL] [Abstract] [Full Text] [Related]
9. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, cyp2d6 and smoking.
Warwick A; Sarhanis P; Redman C; Pemble S; Taylor JB; Ketterer B; Jones P; Alldersea J; Gilford J; Yengi L
Carcinogenesis; 1994 Dec; 15(12):2841-5. PubMed ID: 8001244
[TBL] [Abstract] [Full Text] [Related]
10. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 cyp2d6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking.
Warwick AP; Redman CW; Jones PW; Fryer AA; Gilford J; Alldersea J; Strange RC
Br J Cancer; 1994 Oct; 70(4):704-8. PubMed ID: 7917923
[TBL] [Abstract] [Full Text] [Related]
